New study aims to catch pancreatic cancer sooner in diabetics
NCT ID NCT04662879
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large study is testing whether a risk-scoring tool (called ENDPAC) can identify people with new-onset diabetes who are at higher risk for pancreatic cancer. About 8,800 participants aged 50-85 will have their medical records checked for age, weight changes, and blood sugar trends. Those flagged as high risk will get a CT or MRI scan to look for early signs of pancreatic cancer. The goal is to see if this approach can detect the cancer earlier than usual.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a screening method that catches pancreatic cancer earlier in people with new-onset diabetes, potentially improving survival.
What could go wrong
This is an observational study, not a treatment trial. The algorithm may not prove accurate enough for widespread use, and early detection does not guarantee better outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Kaiser Permanente Southern California, Kaiser Permanente Research
Pasadena, California, 91101, United States